NCT05969418Completed
Deep Learning Optical Coherence Tomography (OCT) and OCT Angiography (OCTA) in NVC
Deep Learning OCT and OCTA Quantification in Neovascular Age Related Macular Degeneration
Source: ClinicalTrials.gov · Last updated 22 May 2024
Brief summary (registry, in English)
To evaluate the activity of neovascular macula degeneretion as assessed by SD-OCTand OCT-A using a split-person study design and deep-learning quantification.
- Status (registry)
- Completed
- Study type
- Observational
- Enrollment
- 50 (actual)
- First submitted
- 23 Jul 2023
- Start date
- 1 Jul 2023
- Primary completion date
- 20 Jul 2023
- Lead sponsor
- Federico II University
- Diseases
- Macular degeneration
- NCT number
- NCT05969418
What you commit to
- Study type: Observational
- Participants enrolled: 50
- From 1 Jul 2023 to the primary completion date, 20 Jul 2023
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- previous retinal surgery and congenital eye diseases
Other
- errors of refraction
- lens opacities
- low-quality OCT and OCTA images
Who the study is looking for
- diagnosis of neovascular macular degeneration
- absence of previous retinal surgery and congenital eye diseases.
- absence of errors of refraction
- absence of lens opacities
- absence of low-quality OCT and OCTA images
Age in the registry: 50 years to 90 years · Sex: All · Accepts healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Federico II University Coordinator of this site? Confirm its status | Naples | Italy | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.